Financhill
Buy
55

ATEN Quote, Financials, Valuation and Earnings

Last price:
$18.52
Seasonality move :
-5.37%
Day range:
$18.14 - $18.75
52-week range:
$12.27 - $19.37
Dividend yield:
1.3%
P/E ratio:
27.64x
P/S ratio:
5.40x
P/B ratio:
6.29x
Volume:
3.8M
Avg. volume:
861.3K
1-year change:
41.37%
Market cap:
$1.4B
Revenue:
$251.7M
EPS (TTM):
$0.67
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $212.6M $225.5M $250M $280.3M $251.7M
Revenue Growth (YoY) -8.44% 6.07% 10.87% 12.12% -10.22%
 
Cost of Revenues $48.9M $50.1M $53.5M $56.8M $48M
Gross Profit $163.7M $175.4M $196.5M $223.5M $203.7M
Gross Profit Margin 77.01% 77.76% 78.6% 79.73% 80.95%
 
R&D Expenses $61.8M $58.1M $54.1M $58.4M $55.2M
Selling, General & Admin $116.5M $99.6M $109.1M $112M $109.9M
Other Inc / (Exp) -$2.5M -- -- -- --
Operating Expenses $178.3M $157.6M $163.1M $170.4M $165.1M
Operating Income -$14.6M $17.7M $33.4M $53.1M $38.6M
 
Net Interest Expenses -- -- $1.7M $363K --
EBT. Incl. Unusual Items -$16.4M $19.1M $31.6M $52.7M $43.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.4M $1.3M -$63.2M $5.8M $3.8M
Net Income to Company -$17.8M $17.8M $94.9M $46.9M $40M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$17.8M $17.8M $94.9M $46.9M $40M
 
Basic EPS (Cont. Ops) -$0.23 $0.23 $1.23 $0.62 $0.54
Diluted EPS (Cont. Ops) -$0.23 $0.22 $1.19 $0.60 $0.53
Weighted Average Basic Share $76.1M $77.8M $77M $75.5M $74.2M
Weighted Average Diluted Share $76.1M $80M $80M $77.8M $75.6M
 
EBITDA -$6.1M $30.5M $42.7M $61.8M $48M
EBIT -$16.2M $19.2M $33.8M $54.4M $38.6M
 
Revenue (Reported) $212.6M $225.5M $250M $280.3M $251.7M
Operating Income (Reported) -$14.6M $17.7M $33.4M $53.1M $38.6M
Operating Income (Adjusted) -$16.2M $19.2M $33.8M $54.4M $38.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $56.6M $65.4M $72.1M $57.8M $66.7M
Revenue Growth (YoY) 7.15% 15.46% 10.25% -19.82% 15.48%
 
Cost of Revenues $13.1M $13.2M $14.8M $11M $13M
Gross Profit $43.5M $52.2M $57.3M $46.8M $53.7M
Gross Profit Margin 76.82% 79.81% 79.51% 80.95% 80.46%
 
R&D Expenses $13.7M $13.6M $14.4M $17.6M $15.7M
Selling, General & Admin $23.6M $28.3M $27.3M $26.9M $27.5M
Other Inc / (Exp) -- -$264K -$871K $987K $2.3M
Operating Expenses $37.2M $41.9M $41.6M $44.6M $43.2M
Operating Income $6.2M $10.3M $15.7M $2.2M $10.4M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $6.7M $10.1M $15.2M $5M $14.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $256K -$64.8M $3.1M -$1.5M $1.8M
Net Income to Company $6.5M $74.9M $12.1M $6.5M $12.6M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $6.5M $74.9M $12.1M $6.5M $12.6M
 
Basic EPS (Cont. Ops) $0.08 $0.97 $0.16 $0.09 $0.17
Diluted EPS (Cont. Ops) $0.08 $0.94 $0.16 $0.09 $0.17
Weighted Average Basic Share $78.2M $77.1M $75.9M $74.5M $73.8M
Weighted Average Diluted Share $80.4M $79.9M $77.7M $75.8M $74.8M
 
EBITDA $8.9M $12.6M $17.5M $4.7M $13.2M
EBIT $6.2M $10.3M $15.7M $2.2M $10.4M
 
Revenue (Reported) $56.6M $65.4M $72.1M $57.8M $66.7M
Operating Income (Reported) $6.2M $10.3M $15.7M $2.2M $10.4M
Operating Income (Adjusted) $6.2M $10.3M $15.7M $2.2M $10.4M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $223.2M $242M $273.4M $258.9M $257.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $50.1M $52.8M $55.3M $50.4M $49.8M
Gross Profit $173.1M $189.2M $218.1M $208.5M $208.1M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $57.7M $56.7M $54.5M $60.2M $56.5M
Selling, General & Admin $102.8M $103.3M $114.9M $111.4M $108M
Other Inc / (Exp) -- -$472K -$1.2M $653K $5.9M
Operating Expenses $160.5M $159.9M $169.4M $171.6M $164.5M
Operating Income $12.6M $29.3M $48.7M $36.9M $43.6M
 
Net Interest Expenses -- $552K $1.3M -- --
EBT. Incl. Unusual Items $11.5M $28.3M $47.9M $41.1M $55.7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.4M -$63.7M $8.3M $984K $5.9M
Net Income to Company $10M $92M $39.6M $40.1M $49.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $10M $92M $39.6M $40.1M $49.8M
 
Basic EPS (Cont. Ops) $0.13 $1.19 $0.52 $0.55 $0.67
Diluted EPS (Cont. Ops) $0.13 $1.15 $0.50 $0.53 $0.67
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $21.9M $40.4M $56.5M $46.9M $54.3M
EBIT $10.5M $30.8M $49.1M $38.2M $43.6M
 
Revenue (Reported) $223.2M $242M $273.4M $258.9M $257.9M
Operating Income (Reported) $12.6M $29.3M $48.7M $36.9M $43.6M
Operating Income (Adjusted) $10.5M $30.8M $49.1M $38.2M $43.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $162.9M $179.4M $202.7M $181.3M $187.5M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $36.7M $39.3M $41.1M $34.7M $36.5M
Gross Profit $126.2M $140M $161.6M $146.6M $151M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $42.5M $41.1M $41.5M $43.3M $44.5M
Selling, General & Admin $73.8M $77.5M $83.3M $82.7M $80.9M
Other Inc / (Exp) -- -$472K -$1.2M $653K $5.9M
Operating Expenses $116.2M $118.5M $124.8M $126M $125.4M
Operating Income $9.9M $21.5M $36.8M $20.6M $25.6M
 
Net Interest Expenses -- $1.2M -- -- --
EBT. Incl. Unusual Items $10.9M $20.1M $36.3M $24.7M $36.6M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $909K -$64.1M $7.5M $2.6M $4.8M
Net Income to Company $10M $84.2M $28.9M $22.1M $31.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $10M $84.2M $28.9M $22.1M $31.8M
 
Basic EPS (Cont. Ops) $0.13 $1.09 $0.38 $0.30 $0.43
Diluted EPS (Cont. Ops) $0.13 $1.05 $0.37 $0.29 $0.43
Weighted Average Basic Share $234.5M $230.6M $228.6M $222.5M $222.6M
Weighted Average Diluted Share $238.5M $238.9M $235.3M $226.8M $225.6M
 
EBITDA $18.7M $28.6M $42.4M $27.5M $33.8M
EBIT $9.9M $21.5M $36.8M $20.6M $25.6M
 
Revenue (Reported) $162.9M $179.4M $202.7M $181.3M $187.5M
Operating Income (Reported) $9.9M $21.5M $36.8M $20.6M $25.6M
Operating Income (Adjusted) $9.9M $21.5M $36.8M $20.6M $25.6M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $45.7M $83.3M $78.9M $68M $97.2M
Short Term Investments $84.2M $74.9M $106.1M $83M $62.1M
Accounts Receivable, Net $53.6M $51.1M $61.8M $72.9M $74.3M
Inventory $22.4M $20.7M $22.5M $19.7M $23.5M
Prepaid Expenses $6.2M $3.8M $4.3M $5.3M $6.1M
Other Current Assets $2.7M $3.2M $3M $1.9M $2.4M
Total Current Assets $220.9M $242.3M $284M $257M $271.8M
 
Property Plant And Equipment $40.7M $36.1M $33.6M $40.9M $46.3M
Long-Term Investments -- -- -- -- --
Goodwill $1.3M $1.3M $1.3M $1.3M $1.3M
Other Intangibles $2.3M $862K -- -- --
Other Long-Term Assets $2M $2.8M $1.9M $655K $1.6M
Total Assets $274.1M $290.8M $393.1M $369.1M $389.8M
 
Accounts Payable $7.6M $4.9M $6.9M $6.7M $7M
Accrued Expenses $6.1M $8.2M $7.1M $10.9M $7.3M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $5.1M $5.3M $4M $4.8M $5M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $97.6M $107.8M $116.1M $118.2M $111.1M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $165.3M $174.8M $184.2M $188.1M $181.9M
 
Common Stock $1K $1K $1K $1K $1K
Other Common Equity Adj $251K $98K -$229K -$726K -$71K
Common Equity $108.8M $116M $208.9M $181M $207.9M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $108.8M $116M $208.9M $181M $207.9M
 
Total Liabilities and Equity $274.1M $290.8M $393.1M $369.1M $389.8M
Cash and Short Terms $129.9M $158.1M $185M $151M $159.3M
Total Debt -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $83.1M $85.6M $32.1M $104.2M $78.1M
Short Term Investments $76M $101.8M $95.6M $64.9M $104M
Accounts Receivable, Net $42.8M $46.8M $73.5M $59.1M $64.9M
Inventory $22.6M $19.2M $21.3M $23.6M $23.4M
Prepaid Expenses $3.9M $4.1M $4.8M $5.2M $5.7M
Other Current Assets $2.8M $3.4M $2.4M $1.6M $2M
Total Current Assets $235.3M $267.3M $237.6M $264.6M $283.8M
 
Property Plant And Equipment $7.3M $9.6M $18M $26.1M $37.3M
Long-Term Investments -- -- -- -- --
Goodwill $1.3M $1.3M $1.3M $1.3M $1.3M
Other Intangibles $1.2M $33K -- -- --
Other Long-Term Assets $38.9M $96.2M $30.3M $24.8M $22.7M
Total Assets $284.1M $374.4M $352.7M $377.8M $407.7M
 
Accounts Payable $7.3M $3.8M $6M $8.2M $7.5M
Accrued Expenses $4.7M $6M $6.6M $9.6M $5.9M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $5.2M $4.5M $4.7M $4.9M $4.9M
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $96.8M $103.2M $122.3M $111.3M $127M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $162.4M $170.9M $191.9M $180.9M $190.5M
 
Common Stock $1K $1K $1K $1K $1K
Other Common Equity Adj $258K $2K -$1.3M $334K $214K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $121.7M $203.6M $160.7M $196.9M $217.3M
 
Total Liabilities and Equity $284.1M $374.4M $352.7M $377.8M $407.7M
Cash and Short Terms $159.1M $187.5M $127.8M $169M $182.1M
Total Debt -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$17.8M $17.8M $94.9M $46.9M $40M
Depreciation & Amoritzation $10M $11.3M $8.9M $7.4M $9.3M
Stock-Based Compensation $16.5M $12.3M $14.4M $13.3M $14.1M
Change in Accounts Receivable $599K $2.3M -$10.4M -$10.1M -$679K
Change in Inventories -$5.6M $543K -$1.8M $2M -$6.3M
Cash From Operations -$426K $55.3M $50.1M $66.1M $44.5M
 
Capital Expenditures $4.3M $3.6M $5.2M $10.8M $10.9M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$251K $5.2M -$38.1M $11.1M $13.6M
 
Dividends Paid (Ex Special Dividend) -- -- -$3.9M -$15.9M -$17.8M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -$32.5M -$18.3M -$79.3M -$16M
Other Financing Activities -$1K -- -- -- --
Cash From Financing $5.8M -$22.9M -$16.4M -$88.1M -$28.8M
 
Beginning Cash (CF) $40.6M $45.7M $83.3M $78.9M $68M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $5.1M $37.5M -$4.4M -$11M $29.3M
Ending Cash (CF) $45.7M $83.3M $78.9M $68M $97.2M
 
Levered Free Cash Flow -$4.8M $51.7M $44.9M $55.3M $33.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $6.5M $74.9M $12.1M $6.5M $12.6M
Depreciation & Amoritzation $2.7M $2.3M $1.8M $2.5M $2.7M
Stock-Based Compensation $3.4M $4M $3.5M $4M $4.2M
Change in Accounts Receivable $2.3M $3.5M -$5.5M $10.4M -$8.3M
Change in Inventories -$718K -$61K $561K -$3.6M $1.4M
Cash From Operations $15.9M $21.8M $14M $23.1M $20.1M
 
Capital Expenditures $1M $944K $3.2M $2.7M $3.5M
Cash Acquisitions -- -- -- -- --
Cash From Investing $188K -$4.3M -$16.5M -$23.6M -$5.7M
 
Dividends Paid (Ex Special Dividend) -- -- -$3.8M -$4.5M -$4.4M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -$47.5M -$2.4M -$9.4M
Other Financing Activities -- -- -- -- --
Cash From Financing $1.2M $172K -$49.7M -$6.5M -$13.8M
 
Beginning Cash (CF) $65.8M $67.9M $84.2M $111.2M $77.5M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $17.2M $17.7M -$52.1M -$7M $606K
Ending Cash (CF) $83.1M $85.6M $32.1M $104.2M $78.1M
 
Levered Free Cash Flow $14.9M $20.8M $10.8M $20.4M $16.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $10M $92M $39.6M $40.1M $49.8M
Depreciation & Amoritzation $11.4M $9.6M $7.4M $8.7M $10.7M
Stock-Based Compensation $13.7M $13.8M $13.4M $14.7M $15.2M
Change in Accounts Receivable $2.6M -$4M -$25.9M $15.1M -$6.4M
Change in Inventories -$2.2M $2.8M -$2.7M -$3.8M -$2.9M
Cash From Operations $44M $58M $47.7M $69.1M $67.5M
 
Capital Expenditures $3M $4.4M $10M $10.3M $13M
Cash Acquisitions -- -- -- -- --
Cash From Investing $7.3M -$31.5M -$6.1M $24M -$48M
 
Dividends Paid (Ex Special Dividend) -- -- -$15.4M -$17.8M -$17.8M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -$13.3M -$30.4M -$86.3M -$8.7M -$31.6M
Other Financing Activities -- -- -- -- --
Cash From Financing -$4.3M -$23.9M -$95M -$21.1M -$45.6M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $47M $2.6M -$53.5M $72M -$26.1M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $41.1M $53.6M $37.6M $58.8M $54.5M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $10M $84.2M $28.9M $22.1M $31.8M
Depreciation & Amoritzation $8.8M $7M $5.5M $6.8M $8.2M
Stock-Based Compensation $9.4M $10.8M $9.8M $11.2M $12.3M
Change in Accounts Receivable $10.8M $4.4M -$11.1M $14.1M $8.4M
Change in Inventories -$810K $1.4M $530K -$5.3M -$1.9M
Cash From Operations $38.5M $41.2M $38.8M $41.8M $64.8M
 
Capital Expenditures $2.5M $3.4M $8.3M $7.8M $9.9M
Cash Acquisitions -- -- -- -- --
Cash From Investing $5.4M -$31.4M $540K $13.4M -$48.2M
 
Dividends Paid (Ex Special Dividend) -- -- -$11.5M -$13.4M -$13.4M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -$13.3M -$11.2M -$79.3M -$8.7M -$24.3M
Other Financing Activities -- -- -- -- --
Cash From Financing -$6.6M -$7.5M -$86.1M -$19M -$35.8M
 
Beginning Cash (CF) $177.2M $226.9M $230.9M $247.7M $297.6M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $37.3M $2.4M -$46.8M $36.2M -$19.2M
Ending Cash (CF) $214.5M $229.3M $184.1M $283.9M $278.4M
 
Levered Free Cash Flow $36M $37.8M $30.5M $34M $54.9M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock